尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the complete record of transactions filed by Fisher Mary, 董事. Director active across 3 companies, notably Sientra, Inc.. Cumulatively, 8 reports have been recorded. History available since 10 June 2021. The latest transaction was disclosed on 15 June 2023 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 条申报中的 8 条
Mary Fisher is a Director at Sientra, Inc. and Dermata Therapeutics, Inc. In this role, she contributes to governance and strategic decision-making. Mary brings her expertise and advice to help guide the direction of the companies, ensuring they meet their objectives.